PlenOptika

Cambridge, United States Founded: 2014 • Age: 12 yrs
Developer of a medical devices for measuring refractive errors
Request Access

About PlenOptika

PlenOptika is a company based in Cambridge (United States) founded in 2014 by Nicholas Durr, Daryl Lim, Eduardo Lage, and Shivang Dave.. PlenOptika has raised $50.38 thousand across 3 funding rounds from investors including HHS. PlenOptika offers products and services including QuickSee Free and QuickSee Free Pro. PlenOptika operates in a competitive market with competitors including machineMD, ArcScan, EyeNetra, Smart Vision Labs and BroadSpot Imaging, among others.

  • Headquarter Cambridge, United States
  • Founders Nicholas Durr, Daryl Lim, Eduardo Lage, Shivang Dave
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
Operational Areas
Healthcare → Healthcare Products & Supplies
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $50.38 K (USD)

    in 3 rounds

  • Latest Funding Round
    $300.14 K (USD), Grant

    Sep 30, 2017

  • Investors
  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of PlenOptika

PlenOptika offers a comprehensive portfolio of products and services, including QuickSee Free and QuickSee Free Pro. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Device for quick and accurate eye refraction measurements in various settings.

Advanced tool for refraction and corneal curvature assessment in clinical use.

People of PlenOptika
Headcount 10-50
Employee Profiles 11
Board Members and Advisors 15
Employee Profiles
People
Ignacio Casares Aláez
Design & Service Engineer
People
Carlos Santiago Hernández
Director of Engineering
People
Eric Norman
Director of Communications
People
Eduardo Lage
CTO

Unlock access to complete

Board Members and Advisors
people
Dave Sattler
Advisor
people
Huy Tran
Advisor
people
Gary Y. Chu
Advisor
people
Thomas A Wong
Advisor

Unlock access to complete

Funding Insights of PlenOptika

PlenOptika has successfully raised a total of $50.38K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $300.14 thousand completed in September 2017. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round Grant — $300,139
  • First Round

    (30 Sep 2015)

  • Investors Count 1
Date Amount Transaction Name Valuation Lead Investors Investors
Sep, 2017 Amount Grant - PlenOptika Valuation

investors

HHS
Aug, 2017 Amount Seed - PlenOptika Valuation

investors

Sep, 2015 Amount Grant - PlenOptika Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in PlenOptika

PlenOptika has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by PlenOptika

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - PlenOptika

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Plenoptika Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of PlenOptika

PlenOptika operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as machineMD, ArcScan, EyeNetra, Smart Vision Labs and BroadSpot Imaging, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Diagnostic device for brain diseases is developed by machineMD.
domain founded_year HQ Location
Ultrasound device for micron-resolution anterior chamber imaging is provided.
domain founded_year HQ Location
Refractive errors are measured using smartphone camera attachments.
domain founded_year HQ Location
Refractive errors are tested via smartphone attachment by healthcare professionals.
domain founded_year HQ Location
Ophthalmological imaging devices for anterior as well as posterior regions
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Plenoptika

Frequently Asked Questions about PlenOptika

When was PlenOptika founded?

PlenOptika was founded in 2014 and raised its 1st funding round 1 year after it was founded.

Where is PlenOptika located?

PlenOptika is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.

Who is the current CEO of PlenOptika?

Shivang Dave is the current CEO of PlenOptika. They have also founded this company.

Is PlenOptika a funded company?

PlenOptika is a funded company, having raised a total of $50.38K across 3 funding rounds to date. The company's 1st funding round was a Grant of $2.65M, raised on Sep 30, 2015.

What does PlenOptika do?

PlenOptika is a developer of medical devices for measuring refractive errors. The objective of the device is based on dynamic aberrometry and smart Rx algorithms. It helps to precisely determine low-order refractive errors. The device is binocular with an open view to help reduce instrument induced myopia.

Who are the top competitors of PlenOptika?

PlenOptika's top competitors include machineMD, EyeNetra and Smart Vision Labs.

What products or services does PlenOptika offer?

PlenOptika offers QuickSee Free and QuickSee Free Pro.

Who are PlenOptika's investors?

PlenOptika has 1 investor. Key investors include HHS.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available